Session 3 - Case reports – risk factors for anti-CGRP targeting treatments

Annelies Van Dycke

MD, PhD Neurologist, AZ Sint-Jan, Bruges, Belgium

The prevalence of epilepsy is 0.5—1.0% and that of migraine is 15—18% in women, 6% in men and 4% in children. Epidemiological studies show that comorbidity between these disorders is high, with migraine occurring in about 25% of people with epilepsy and epilepsy reported in 1—2% of people with migraine.

References

1. Haut SR, Bigal ME, Lipton RB. Chronic disorders with episodic manifestations: focus on epilepsy and migraine. Lancet Neurol. 2006;5:148-157.